Hertzel C Gerstein
Overview
Explore the profile of Hertzel C Gerstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
359
Citations
18768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El Khalili L, El Khalili L, Rawshani A, Boren J, Bhatt D, Gerstein H, et al.
Cardiovasc Diabetol
. 2025 Mar;
24(1):117.
PMID: 40075392
Objective: To investigate standardized incidence of atrial fibrillation (AF) in individuals with type 1 diabetes (T1DMM) compared with matched controls from the general population. Additionally, to examine optimal levels- and...
2.
Vinograd A, Lerman T, Pinhas-Hamiel O, Bardugo A, Bendor C, Derazne E, et al.
Diabetes Care
. 2025 Feb;
PMID: 40009774
Objective: We assess diabetes risk in adulthood among adolescents with isolated glucosuria. Research Design And Methods: Included were adolescents (16-19 years) examined before military service between 1993 and 2015. Data...
3.
Lee M, Ghouri N, Misra A, Kang Y, Rutter M, Gerstein H, et al.
Diabetes Care
. 2025 Feb;
48(3):489-493.
PMID: 39977628
Background: Cardiovascular outcome trials (CVOTs) suggest glucagon-like peptide 1 receptor agonists (GLP-1RAs) provide greater cardiovascular (CV) benefits in Asian compared with White individuals. Purpose: Compare CV efficacy of GLP-1RAs between...
4.
Moayad L, Alliston P, Khalid S, Fitzpatrick-Lewis D, Gerstein H, Sherifali D
J Patient Exp
. 2025 Jan;
12():23743735251314620.
PMID: 39839486
Diabetes registries have grown in prevalence and incorporated patient engagement opportunities to support diabetes management. We aimed to understand the goals, purpose, and context for diabetes registries defined as patient-focused...
5.
Gerstein H, Mohammedi K
Lancet Diabetes Endocrinol
. 2025 Jan;
13(2):78-79.
PMID: 39818227
No abstract available.
6.
Wu A, Pu J, Emery A, Harris S, Reichert S, Gerstein H, et al.
Diabetes Obes Metab
. 2024 Nov;
27(3):1132-1142.
PMID: 39609927
Aims: When administered in early type 2 diabetes (T2DM), the strategy of 'induction' with short-term intensive insulin therapy (IIT) followed by 'maintenance' with metformin thereafter can yield outstanding glycaemic control,...
7.
Badve S, Bilal A, Lee M, Sattar N, Gerstein H, Ruff C, et al.
Lancet Diabetes Endocrinol
. 2024 Nov;
13(1):15-28.
PMID: 39608381
Background: GLP-1 receptor agonists reduce the risk of major adverse cardiovascular events (MACE) and can also have kidney benefits. However, whether GLP-1 receptor agonists improve clinically important kidney outcomes remains...
8.
Zloof Y, Nitecki M, Simchoni M, Adar O, Tsur A, Derazne E, et al.
Lancet Diabetes Endocrinol
. 2024 Nov;
13(2):97-106.
PMID: 39557052
Background: Morbidities related to obesity are usually associated with its severity and duration. Yet, the onset of serious morbidities in early adulthood among otherwise healthy adolescents with obesity is understudied....
9.
Marx N, Ryden L, Federici M, Marx-Schutt K, Verket M, Muller-Wieland D, et al.
Eur Heart J
. 2024 Oct;
45(48):5117-5126.
PMID: 39387537
With the increasing burden of diabetes as a cause of macro- and microvascular disease linked to the epidemics of obesity, attention is being paid to dysglycaemic states that predict and...
10.
Lee S, Whiteley W, Bosch J, Sherlock L, Cukierman-Yaffe T, ODonnell M, et al.
Trials
. 2024 Oct;
25(1):644.
PMID: 39358761
Background: The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) questionnaires are commonly used to measure global cognition in clinical trials. Because these scales are discrete and bounded...